Neurocrine Biosciences to Present at Upcoming Investor Conferences in March
Neurocrine Biosciences (Nasdaq: NBIX) said members of management will present at investor conferences in March 2026, including TD Cowen on March 3 at 11:50 AM ET and Leerink Global on March 9 at 8:40 AM ET.
Rhea-AI Summary
Neurocrine Biosciences (Nasdaq: NBIX) said members of management will present at investor conferences in March 2026, including TD Cowen on March 3 at 11:50 AM ET and Leerink Global on March 9 at 8:40 AM ET.
Live webcasts will stream on the company's investor website with replays posted about one hour after each event and archived for roughly one month.
Positive
- None.
Negative
- None.
Details
News Market Reaction – NBIX
On Feb 25, the first trading day after this news, NBIX closed 0.15% above the previous close.
Data tracked by StockTitan Argus for the Feb 25 session.
AI-generated analysis. How Rhea-AI works. Not financial advice.
- TD Cowen 46th Annual Health Care Conference. Fireside chat on Tuesday, March 3, 2026 at 11:50 AM ET in
Boston - Leerink Global Healthcare Conference. Fireside chat on Monday, March 9, 2026 at 8:40 AM ET in
Miami
The live webcasts can be accessed on Neurocrine Biosciences' website under Investors at www.neurocrine.com. A replay of the webcasts will be available on the website approximately one hour after the conclusion of the events and will be archived for approximately one month.
About Neurocrine Biosciences
Neurocrine Biosciences is a leading biopharmaceutical company with a simple purpose: to relieve suffering for people with great needs. We are dedicated to discovering, developing and commercializing life-changing treatments for patients with under-addressed neurological, psychiatric, endocrine and immunological disorders. The company's diverse portfolio includes FDA-approved treatments for tardive dyskinesia, chorea associated with
NEUROCRINE, the NEUROCRINE BIOSCIENCES Logo and YOU DESERVE BRAVE SCIENCE are registered trademarks of Neurocrine Biosciences, Inc.
View original content to download multimedia:https://www.prnewswire.com/news-releases/neurocrine-biosciences-to-present-at-upcoming-investor-conferences-in-march-302696148.html
SOURCE Neurocrine Biosciences, Inc.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.